139 related articles for article (PubMed ID: 2861219)
1. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral procaterol and albuterol in reversible airflow obstruction.
Petty TL; Brandon ML; Busse WW; Chervinsky P; Schoenweter W; Beaupre A; Boulet LP; Mazza J
Am Rev Respir Dis; 1988 Dec; 138(6):1504-9. PubMed ID: 2974263
[TBL] [Abstract][Full Text] [Related]
3. Procaterol metered-dose inhaler: a multiclinic study evaluating the efficacy and safety in patients with asthma.
Storms WW; Chervinsky P; Bell T; Kemp JP; Brandon ML; Reed CE; Siegel SC; Repsher L
Ann Allergy; 1989 Nov; 63(5):444-8. PubMed ID: 2573298
[TBL] [Abstract][Full Text] [Related]
4. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
Boner AL; Sette L; Castellani C; Schiassi M
J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
Tinkelman DG; DeJong R; Lutz C; Spangler DL
J Allergy Clin Immunol; 1990 Apr; 85(4):719-28. PubMed ID: 1969869
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Mazza JA; Tashkin DP; Reed CE
Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
[TBL] [Abstract][Full Text] [Related]
7. Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study.
Dahl R; Harving H; Henriksen J; Rønne K; Schøler P
Allergy; 1985 Oct; 40(7):501-5. PubMed ID: 2933998
[TBL] [Abstract][Full Text] [Related]
8. Inhaled procaterol versus salbutamol in bronchial asthma.
Liippo K; Silvasti M; Tukiainen H
Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
[TBL] [Abstract][Full Text] [Related]
9. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma.
Kemp JP; Welch MJ; Meltzer EO; Orgel HA
Ann Allergy; 1985 Oct; 55(4):588-92. PubMed ID: 2864890
[TBL] [Abstract][Full Text] [Related]
11. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness.
Busse WW; Sharpe G; Smith A; Arbabian M; Borgen L; Ruoho A
Am Rev Respir Dis; 1985 Dec; 132(6):1194-8. PubMed ID: 3000233
[TBL] [Abstract][Full Text] [Related]
12. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies].
Cammarata A; Mazzarella G; Grella E; Liccardo G
Arch Monaldi Mal Torace; 1988; 43(2):131-40. PubMed ID: 2908377
[No Abstract] [Full Text] [Related]
13. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
Morin D; Milot J; Turcotte H; Boulet LP
Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
15. Comparison between oral procaterol and salbutamol in patients with bronchial asthma.
Tukiainen H; Jaakkola J; Torkko M; Terho EO
Curr Med Res Opin; 1988; 11(4):236-41. PubMed ID: 2975204
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect.
Mitsuhashi M; Kimura T; Tateno K; Morikawa A; Kuroume T
J Asthma; 1985; 22(4):203-7. PubMed ID: 2931421
[TBL] [Abstract][Full Text] [Related]
17. The effect of diet on the efficacy onset and duration of action of procaterol hydrochloride tablets.
Spangler DL; Lutz CN; Tinkelman D
Ann Allergy; 1987 Jan; 58(1):59-62. PubMed ID: 2948431
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and duration of action of procaterol, a new bronchodilator.
Zanetti CL; Rotman HH; Dresner AJ
J Clin Pharmacol; 1982; 22(5-6):250-3. PubMed ID: 6213680
[TBL] [Abstract][Full Text] [Related]
19. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
[TBL] [Abstract][Full Text] [Related]
20. The utility of a long-acting sympathomimetic agent, procaterol, for nocturnal asthma.
Baughman RP; Loudon RG
Chest; 1988 Feb; 93(2):285-8. PubMed ID: 2962837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
